Clinical Trial Applications: Filter, Search, and view applications
# | Protocol No | Study Title | Investigator(s) & Site(s) | |
---|---|---|---|---|
116. |
ECCT/16/02/04 | comparison of weight adjusted versus fixed dose ondansetron in preventing shivering following spinal anesthesia for cesarean deliveries COMPARISON OF WEIGHT ADJUSTED DOSE VERSUS FIXED DOSE ONDANSETRON IN PREVENTING SHIVERING FOLLOWING SPINAL ANESTHESIA FOR CESAREAN DELIVERIES. |
Principal Investigator(s) 1. moses kimuri gicheru KIMURI gicheru Site(s) in Kenya AGA kHAN UNIVERSITY HOSPITAL |
View |
117. |
ECCT/16/02/05 | PfSPZ Malaria Vaccine Safety, Tolerability and Efficacy of PfSPZ Vaccine Administered by Direct Venous Inoculation (DVI) to Healthy Children and Infants 5 Months through 12 Years of Age Living in an Area of High Malaria Transmission in Western Kenya: Age de-escalation and Dose Escalation and a Double Blind, Randomized Placebo-Controlled Trial for Safety and Efficacy |
Principal Investigator(s) 1. Martina Oneko 2. Mary J Hamel Site(s) in Kenya 1. Siaya County Referral Hospital (Siaya county) 2. Wagai Health Center (Siaya county) |
View |
118. |
ECCT/16/02/06 | A study of the safety and immune response of 2 doses of a new Shigella vaccine in Kenyan adults. A Phase 2a, observer blind, randomized, controlled, Single Center Study to evaluate the Safety, Reactogenicity and Immunogenicity of 2 doses of the GVGH 1790GAHB Vaccine against Shigella sonnei, administered intramuscularly in Adult Subjects from a country endemic for shigellosis [GVGH study H03_04TP] |
Principal Investigator(s) 1. Christina Wesonga Obiero Site(s) in Kenya Kenya Medical Research Institute (KEMRI) -Wellcome Trust Research Programme |
View |
119. |
ECCT/16/03/02 | Infant TB Infection Prevention Study (“iTIPS”) Preventing Mycobacterium Tuberculosis Infection in HIV-Exposed Infants |
Principal Investigator(s) 1. Grace John-Stewart Site(s) in Kenya 1. Kisumu East District Hospital (Kisumu county) 2. Ahero County Hospital (Kisumu county) 3. Bondo sub-County Hospital (Kisumu county) |
View |
120. |
ECCT/16/04/01 | HVTN 703/HPTN 081 Protocol A phase 2b study to evaluate the safety and efficacy of VRC01 broadly neutralizing monoclonal antibody in reducing acquisition of HIV-1 infection HVTN 703/HPTN 081 A phase 2b study to evaluate the safety and efficacy of VRC01 broadly neutralizing monoclonal antibody in reducing acquisition of HIV-1 infection |
Principal Investigator(s) 1. Dr. Victor Akelo Akelo Site(s) in Kenya KISUMU CRS |
View |